Activation of the PI3K/AKT pathway and PIK3CA mutations in Merkel cell carcinoma

被引：0
|
作者：
Hafner, C. [1 ]
Houben, R. [2 ]
Baeurle, A. [2 ]
Landthaler, M. [1 ]
Becker, J. C. [2 ,3 ]
机构：
[1] Dermatol Klin & Poliklin, Regensburg, Germany
[2] Univ Wurzburg, Dermatol Klin, Wurzburg, Germany
[3] Med Univ Graz, Dept Gen Dermatol, Graz, Austria
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2010年 / 8卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：739 / 739
页数：1
相关论文
共 50 条
  • [1] Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
    Hafner, Christian
    Houben, Roland
    Baeurle, Anne
    Ritter, Cathrin
    Schrama, David
    Landthaler, Michael
    Becker, Juergen C.
    [J]. PLOS ONE, 2012, 7 (02):
  • [2] PIK3CA Mutations PREDICT RESPONSE TO PI3K/AKT/mTOR INHIBITORS
    不详
    [J]. CANCER DISCOVERY, 2012, 2 (03) : 205 - 205
  • [3] Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers
    Fang, Wen-Liang
    Huang, Kuo-Hung
    Lan, Yuan-Tzu
    Lin, Chien-Hsing
    Chang, Shih-Ching
    Chen, Ming-Huang
    Chao, Yee
    Lin, Wen-Chang
    Lo, Su-Shun
    Li, Anna Fen-Yau
    Wu, Chew-Wun
    Chiou, Shih-Hwa
    Shyr, Yi-Ming
    [J]. ONCOTARGET, 2016, 7 (05) : 6201 - 6220
  • [4] Screening for PIK3CA, RAS, and RAF mutations in trials with PI3K/AKT/mTOR signaling pathway inhibitors
    Janku, F.
    Tsimberidou, A. M.
    Garrido-Laguna, I.
    Hong, D. S.
    Naing, A. M.
    Falchook, G. S.
    Fu, S.
    Luthra, R.
    Wang, X.
    Kurzrock, R.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 83 - 83
  • [5] Targeting PI3K/AKT Pathway is an Effective Strategy for the Treatment of Neuroendocrine Tumors Harboring PIK3CA Mutations
    Song, Jun
    Li, Jing
    Kim, Ji Tae
    Weiss, Heidi
    Townsend, Courtney M.
    Evers, B. N.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S116 - S117
  • [6] Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
    Zheng, Shutao
    He, Shuo
    Liang, Yan
    Tan, Yiyi
    Liu, Qing
    Liu, Tao
    Lu, Xiaomei
    [J]. MOLECULAR BIOMEDICINE, 2024, 5 (01):
  • [7] The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC
    Ekizoglu, S.
    Dogan, S.
    Ulker, D.
    Seven, D.
    Gozen, E. D.
    Karaman, E.
    Buyru, N.
    [J]. CLINICAL OTOLARYNGOLOGY, 2015, 40 (06) : 622 - 628
  • [8] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    [J]. JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
  • [9] PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway
    Guan, Ruijuan
    Kang, Zefeng
    Li, Ling
    Yan, Xin
    Gao, Tianpeng
    [J]. PLOS ONE, 2024, 19 (01):
  • [10] Activation of PI3K in Merkel cell carcinoma
    Nardi, Valentina
    Song, Young Chul
    Cosper, Arjola K.
    Quynh Lam
    Barria, Juan Antonio Santamaria
    Boland, Genevieve Marie
    Yeap, Beow
    Bergethon, Kristin
    Scialabba, Vanessa L.
    Settleman, Jeffrey
    Ryan, David P.
    Borger, Darrell R.
    Hoang, Mai P.
    Bhan, Atul K.
    Iafrate, Anthony J.
    Cusack, James C.
    Engelman, Jeffrey A.
    Dias-Santagata, Dora
    [J]. CANCER RESEARCH, 2011, 71
12345